Pricing Log in Create free account
Friday 6 November 2026 Export DXCM’s income statement to Excel — free account

DexCom, Inc.

DXCM Healthcare Medical Devices

DexCom, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $4.7 billion, up 15.6% from fiscal 2024.

Revenue
+11.2%
EPS
0.00%
Free cash flow
−52.9%
Total debt
+0.31%

Quarter to September 2026, against a year earlier

79.96 4.50 −5.33%
Market cap
$31.5B
P/E
32.6×
Fwd P/E
31.8×
Dividend yield
—
F-score
8/9
Altman Z
6.43
Beneish M
−2.70
Dividend safety
n/a
Overview Business Profile Earnings & Analysis
Financials
Income Statement Balance Sheet Cash Flow Metrics & Ratios
Segments Valuation Filings

DexCom, Inc. (DXCM) EV/EBITDA

Alert me on EV/EBITDA

As of 5 November 2026, DexCom, Inc. (DXCM) trades at a EV/EBITDA of 21.2×. Over the past ten years it has ranged from 0.0× (December 2019) to 860× (November 2018); the current reading is higher than 43% of that period. That is above the Medical Devices industry median of 11.5× and above the Healthcare sector median of 8.4×.

EV/EBITDA, daily

Embed this chart

Annual newest first

Period EV/EBITDA Change
FY2025 22.3× (39.38%)
FY2024 36.7× (40.01%)
FY2023 61.2× (24.18%)
FY2022 80.8× (41.99%)
FY2021 139× 50.72%
FY2020 92.4× (9.37%)
FY2019 102× —
FY2018 0.0× —
FY2017 0.0× —
FY2016 0.0× —

Quarterly newest first

Period EV/EBITDA Change
Sep 2026 21.7× 18.00%
Jun 2026 18.4× (0.06%)
Mar 2026 18.4× (17.36%)
Dec 2025 22.3× (8.98%)
43 more quarters

Against its own ten years

Low 0.0× High 860×
Ten-year median 29.7×
Current reading's percentile 43

EV/EBITDA against peers

Company EV/EBITDA
GKOS Glaukos Corporation compare n/m
SNN Smith & Nephew SNATS, Inc. compare 6.5×
PHG Koninklijke Philips N.V. compare 11.1×
ZBH Zimmer Biomet Holdings, Inc. compare 12.1×
GEHC GE HealthCare Technologies Inc. compare 13.2×
BSX Boston Scientific Corporation compare 14.0×
STE STERIS plc compare 15.7×
DXCM DexCom, Inc. 21.2×
EW Edwards Lifesciences Corporation compare 34.0×
Medical Devices industry median 11.5×
Healthcare sector median 8.4×
Market median 10.9×

What EV/EBITDA is

Enterprise Value over EBITDA tells an investor how the market values a whole company, with debt added and cash taken off, against its operating earnings.

((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ EBITDA (TTM)

The full definition of EV/EBITDA →

More on DXCM